Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9097 |
High Similarity |
NPD1653 |
Approved |
0.8531 |
High Similarity |
NPD7266 |
Discontinued |
0.8507 |
High Similarity |
NPD1091 |
Approved |
0.8258 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8112 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7963 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7962 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7898 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7866 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7866 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7832 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.78 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7725 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7697 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7679 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7671 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7643 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7589 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7589 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7572 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD5403 |
Approved |
0.756 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7554 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7552 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7547 |
Intermediate Similarity |
NPD37 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD2801 |
Approved |
0.75 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7467 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7394 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7386 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7338 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1933 |
Approved |
0.732 |
Intermediate Similarity |
NPD5762 |
Approved |
0.732 |
Intermediate Similarity |
NPD5763 |
Approved |
0.732 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD968 |
Approved |
0.7303 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD7095 |
Approved |
0.729 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7261 |
Intermediate Similarity |
NPD1511 |
Approved |
0.726 |
Intermediate Similarity |
NPD1203 |
Approved |
0.726 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7259 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7259 |
Intermediate Similarity |
NPD290 |
Approved |
0.725 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7209 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7195 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.719 |
Intermediate Similarity |
NPD5588 |
Approved |
0.719 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD6653 |
Approved |
0.717 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7122 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7122 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7114 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7103 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7088 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD4626 |
Approved |
0.708 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7075 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7074 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7074 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD2796 |
Approved |
0.703 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7014 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7 |
Intermediate Similarity |
NPD3536 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6993 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6986 |
Remote Similarity |
NPD1611 |
Approved |
0.6985 |
Remote Similarity |
NPD9697 |
Approved |
0.6982 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6968 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD5846 |
Approved |
0.6964 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6943 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD9717 |
Approved |
0.6939 |
Remote Similarity |
NPD1608 |
Approved |
0.6933 |
Remote Similarity |
NPD3226 |
Approved |
0.6931 |
Remote Similarity |
NPD7874 |
Approved |
0.6931 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD969 |
Suspended |
0.6923 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6918 |
Remote Similarity |
NPD2677 |
Approved |
0.6915 |
Remote Similarity |
NPD7585 |
Approved |
0.6909 |
Remote Similarity |
NPD4433 |
Discontinued |
0.6908 |
Remote Similarity |
NPD1048 |
Approved |
0.6908 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6905 |
Remote Similarity |
NPD5709 |
Phase 3 |
0.6894 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6892
|
Remote Similarity |
NPD2982 |
Phase 2 |